Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
CLASS: Efficacy of 3TC/ABC-based Regimens in ART-Naive HIV-1
NCT00005017Phase 4Unknown
- Sponsor
- GSK
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 4 trial of abacavir, lamivudine, amprenavir, stavudine, efavirenz in human immunodeficiency virus type 1 infection (HIV-1), sponsored by GSK. Status: unknown.
02
Drugs
abacavirlamivudineamprenavirstavudineefavirenz
03
Conditions
human immunodeficiency virus type 1 infection (HIV-1)
Beyond the preview
Go deeper on NCT00005017.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00005017.